Stay updated with breaking news from Gel Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Equities Research Analysts’ downgrades for Thursday, April 21st: Alcoa (NYSE:AA) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating. They currently have $84.00 price target on the stock. Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating. The firm currently […]
Brokerages expect Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Get Rating) to announce earnings per share of ($0.22) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Sol-Gel Technologies’ earnings, with the highest EPS estimate coming in at ($0.20) and the lowest estimate coming in at ($0.24). Sol-Gel Technologies reported earnings […]
Sol-Gel Technologies (NASDAQ:SLGL – Get Rating)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a note issued to investors on Monday, TipRanks reports. They currently have a $20.00 target price on the stock. HC Wainwright’s price target suggests a potential upside of 178.16% from the company’s current price. Other equities […]
Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Rating) and Sol-Gel Technologies (NASDAQ:SLGL – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends. Insider & Institutional Ownership 18.3% of Cumberland Pharmaceuticals shares are […]
Press release content from PR Newswire. The AP news staff was not involved in its creation.